Q301--Afirma Thyroid Testing VISN 23
Closed Special Notice Posted
- Solicitation number
- 36C26325Q0681
- Agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) Veterans Health Administration, specifically Veterans Integrated Service Network 23 (VISN 23), has issued a Special Notice of Intent to award a sole source, fixed-price indefinite delivery contract to Veracyte, Inc. for specialized thyroid testing services. The contract covers reference laboratory testing for the Veracyte Afirma Genomic Sequencing Classifier (GSC) and Afirma Xpression Atlas (XA) across nine VA healthcare facilities in the Midwest region, including locations in North Dakota, South Dakota, Nebraska, Minnesota, and Iowa. Market research confirmed Veracyte, Inc. as the only authorized provider for these specific thyroid diagnostic services. The Special Notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) to disseminate information about the proposed contract action. The procurement falls under NAICS code 621511 for Medical Laboratories and service code Q301 for Reference Laboratory Testing.
The primary objective of this Special Notice is to provide an opportunity for potential alternative vendors to demonstrate their capability to meet the VA's thyroid testing requirements. Interested vendors are invited to submit capability statements, proposals, or quotations by 11:00 AM Central Time on April 18, 2025, to contract specialist Logan Gahring at logan.gahring@va.gov. While the VA currently understands Veracyte, Inc. to be the sole vendor capable of providing these services, they are open to reviewing documentation from other vendors that might prove competitive. The submitted documentation will be evaluated solely to determine whether the procurement should be conducted on a competitive basis. Eligibility is open to all responsible sources who believe they can fully meet the government's requirement for thyroid testing services. The final determination of whether to compete the procurement remains entirely at the government's discretion, and this notice does not constitute a formal solicitation for competitive quotes.
Notice text
This is a Notice of Intent published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This Notice of Intent is for a proposed award of a sole source, fixed price indefinite delivery contract, as implemented by FAR 13.106-1(b)(2). It is not a request for competitive quotes.
The Department of Veterans Affairs, Network Contracting Office 23 intends to award a sole source, fixed price indefinite delivery contract to Veracyte,Inc,6000 Shoreline Court, Suite 300, South San Francisco, CA 94080. VISN 23 has a requirement for reference laboratory testing for Veracyte Afirma Genomic Sequencing Classifier (GSC) (CPT 81546) and Afirma Xpression Atlas (XA) (CPT 0204U) to provide physicians with a comprehensive solution for a complex landscape in thyroid cancer diagnosis and individualization of care. Veracyte Afirma GSC testing enables physicians to answer multiple clinical questions for their thyroid patients using a single, minimally invasive fine needle aspiration (FNA) sample.
VISN 23 laboratories:
1. Fargo VA Health Care System; Fargo, ND
2. VA Black Hills Health Care System, Hot Springs, SD
3. VA Black Hills Health Care System, Fort Meade, SD
4. VA Nebraska-Western Iowa Health Care System, Omaha, NE
5. St. Cloud VA Healthcare System, St. Cloud, MN
6. Sioux Falls VA Health Care System, Sioux Falls, SD
7. Iowa City VA Health Care System, Iowa City, IA
8. Minneapolis VA Health Care System, Minneapolis, MN
9. VA Central Iowa Health Care System, Des Moines, IA
Market research revealed that Veracyte,Inc is the only authorized services provider for the needed thyroid testing services. The North American Industry Classification System (NAICS) code for this requirement is 621511 and the service code is Q301.
While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy the requirement. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The Government understands that Veracyte,Inc is the only vendor that can provide the requested services. However, vendors that believe they can provide the capabilities required to fully meet the Government's requirement may submit information in writing to logan.gahring@va.gov by 11:00AM Central Time on April 18, 2025. Such documentation will be reviewed solely for the purpose of determining whether to conduct the procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Files
| File | Type | Posted |
|---|---|---|
| 36C26325Q0681.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Q301--Reference Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| 6515--Affera Mapping System - Cinci | Veterans Integrated Service Network 10 | No set-aside | |
| Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC | Veterans Integrated Service Network 20 | No set-aside | |
| NWI Offsite Pathology Services | Veterans Integrated Service Network 23 | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity